DNAprint Genomics (DNAG)

[frogdreaming]

Virgil, I don't think it's that simple.

I think we are all agreed that IF nothing changes, another r/s is highly likely. However, it seems to me that the real question here is how likely is it that nothing changes. It seems to me that we are getting closer every day to generating some significant revenue.

'Significant revenue' is not enough. There is another qualification required in order to stave of another R/S and that is the time period involved. That significant revenue must occur within a time period limited by the remaining shares available for dilution. At current rates that is a matter of months, not years.

Significant revenues two years from now will not be sufficient. Neither Handelin's projects nor the Biofrontera promises suggest any changes in near term revenue increases.

Unless you can foresee significant revenus streams occuring in the next few months, that "maybe" is going to get uncomfortable.

regards,
frog